Role of stromal PD-L1 expression in colorectal liver metastasis by Chie Takasu, Yuji Morine, Kozo Yoshikawa, Toshihiro Nakao, Takuya Tokunaga, Masaaki Nishi, Hideya Kashihara, Yuma Wada, Toshiaki Yoshimoto, Mitsuo Shimada

Subjects: “…Immune check point…”
Get full text

Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock by Osnat Itzhaki Ben Zadok, MD, MS, Ben Ben-Avraham, MD, Anju Nohria, MD, Katia Orvin, MD, Mithal Nassar, MD, Zaza Iakobishvili, MD, PhD, Victoria Neiman, MD, Hadar Goldvaser, MD, Ran Kornowski, MD, Tuvia Ben Gal, MD

Subjects: Get full text

Efficacy of Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer 
with Rare Mutation by Teng LI, Junling LI

Subjects: Get full text

Planned Abscopal Effect with Concurrent Pembrolizumab and Ablative Radiotherapy to Pulmonary Metastasis: A Case Report and Review of the Literature by Yu-Ting Lee, Chien-Chin Chen, Hsiya Chao, Chih-Chia Chang, Cheng-Yen Lee

Subjects: Get full text

Management of Immune Checkpoint Inhibitor Toxicities by Durrechou Q, Domblides C, Sionneau B, Lefort F, Quivy A, Ravaud A, Gross-Goupil M, Daste A

Subjects: “…immune check point inhibitor…”
Get full text

Synergistic effect between denosumab and immune checkpoint inhibitors (ICI)? A retrospective study of 268 patients with ICI and bone metastases by E. Mabrut, S. Mainbourg, J. Peron, D. Maillet, S. Dalle, C. Fontaine Delaruelle, E. Grolleau, P. Clezardin, E. Bonnelye, C.B. Confavreux, E. Massy

Subjects: Get full text

Immune checkpoint inhibitor-related acral vasculitis by Thibault Comont, Vincent Sibaud, Loïc Mourey, Pierre Cougoul, Odile Beyne-Rauzy

Subjects: “…Immune check point inhibitors…”
Get full text

Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective lon... by Javier García-Corbacho, Alberto Indacochea, Iván Victoria, Débora Moreno, Laura Angelats, Azucena E. González Navarro, Laura Mezquita, Fara Brasó-Maristany, Patricia Galván, Begoña Mellado, Nuria Viñolas, Tamara Sauri, Miquel Nogué, Barbara Adamo, Joan Maurel, Estela Pineda, Lydia Gaba, Oscar Reig, Neus Basté, Esther Sanfeliu, Manel Juan, Aleix Prat, Francesco Schettini

Subjects: Get full text

Tumor infiltrating lymphocytes in malignant melanoma - allies or foes? by Vladimir Zidlik, Michala Bezdekova, Svetlana Brychtova

Subjects: Get full text

Imaging features of toxicities associated with immune checkpoint inhibitors by Babina Gosangi, Lacey McIntosh, Abhishek Keraliya, David Victor Kumar Irugu, Akshay Baheti, Ashish Khandelwal, Richard Thomas, Marta Braschi-Amirfarzan

Subjects: “…Immune check point inhibitors toxicity…”
Get full text

Immunotherapy improves efficiency of conversion surgery for metastatic gastric cancer: A case report by Che-Pin Lin, Yung-Chuan Sung, Jia-Uei Wong

Subjects: Get full text

Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression by Khan O. Mohammad, Hanna Fanous, Sneha Vakamudi, Yan Liu

Subjects: “…Immune check point inhibitor…”
Get full text

Molecular Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma Treatment: An Update by Sonja Vukadin, Farah Khaznadar, Tomislav Kizivat, Aleksandar Vcev, Martina Smolic

Subjects: Get full text

BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase Inhibitors by Elizabeth Dudnik, Elizabeth Dudnik, Jair Bar, Jair Bar, Assaf Moore, Teodor Gottfried, Mor Moskovitz, Julia Dudnik, Tzippy Shochat, Aaron M. Allen, Aaron M. Allen, Alona Zer, Alona Zer, Ofer Rotem, Nir Peled, Nir Peled, Damien Urban, Damien Urban

Subjects: Get full text

Frequency and clinical characteristics of hypophysitis and hypopituitarism in patients undergoing immunotherapy – A systematic review by Juliana Prudêncio Jacques, Luciana Pinto Valadares, Adriana Castelo Moura, Maria Regina Fernandes Oliveira, Luciana Ansaneli Naves

Subjects: Get full text

HSV-pneumonitis in a patient with lung cancer receiving check point inhibitors – a case report by Johannes Sumer, Frederike Waldeck, Nadja Fischer, Christina Appenzeller, Markus Koster, Martin Früh, Werner C. Albrich

Subjects: Get full text

Acute tubulointerstitial nephritis associated with atezolizumab, an anti-programmed death-ligand 1 (pd-l1) antibody therapy by M. Xipell, I. Victoria, V. Hoffmann, J. Villarreal, A. García-Herrera, O. Reig, L. Rodas, M. Blasco, E. Poch, B. Mellado, L. F. Quintana

Subjects: Get full text

Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors by Arielle Elkrief, Layal El Raichani, Corentin Richard, Meriem Messaoudene, Wiam Belkaid, Julie Malo, Karl Belanger, Wilson Miller, Rahima Jamal, Nathalie Letarte, Philip Wong, Bertrand Routy

Subjects: Get full text

Complete remission of advanced and recurrent cervical cancer with pembrolizumab treatment- 3 case reports by Hsiu-Jung Tung, Chun-Chieh Wang, Feng-Yuan Liu, Chyong-Huey Lai

Subjects: Get full text

Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune check... by Emily Z. Keung, Jen-Wei Tsai, Ali M. Ali, Janice N. Cormier, Andrew J. Bishop, B. Ashleigh Guadagnolo, Keila E. Torres, Neeta Somaiah, Kelly K. Hunt, Jennifer A. Wargo, Alexander J. Lazar, Wei-Lien Wang, Christina L. Roland

Subjects: Get full text